Status:
COMPLETED
Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With Proteinuria
Lead Sponsor:
Gulhane School of Medicine
Conditions:
Proteinuria
Diabetic Nephropathy
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
In recent years, diabetic nephropathy, which may lead to dialysis treatment, is the most prevalent underlying disease of people in developed countries. A wide range of studies have been carried out, f...
Detailed Description
The patients who were non-obese (BMI \< 30 kg/m2), non dyslipidemic (total cholesterol \< 200 mg/dl, Triglyceride\<150mg/dl), and free of cardiovascular events (negative medical history, negative ECG ...
Eligibility Criteria
Inclusion
- CKD stage 1 patients
- Older than 18 years of age
- Type 2 Diabetic patients
- Proteinuria
Exclusion
- History of coronary artery disease
- Smokers
- Taking statins or renin-angiotensin blockers
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT00893425
Start Date
January 1 2008
End Date
April 1 2009
Last Update
June 3 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gulhane School of Medicine
Ankara, Turkey (Türkiye), 06108